At Nuchem Therapeutics, our primary asset is our knowledgeable and creative scientists. Our pharmaceutically trained researchers draw upon years of experience in early stage drug discovery acquired across a wide range of therapeutic areas and biological targets. Through tractable hit-series identification and productive analogue design and synthesis, we can help you identify and optimise pre-clinical candidates in the area of small molecule drug discovery. Nuchem delivers excellence through thoughtful interpretation and rational integration of SAR and PK/ADME results into the design-make-test-analyse cycle. Our medicinal chemistry team is committed to rapidly advancing your research programs by providing, fast, flexible and innovative solutions. Contact us to discuss your needs.